Parkinson's Disease May Be Linked to Genetic Differences in Brain Cells

New research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026 has identified genetic differences in brain cells that may contribute to the higher prevalence of Parkinson’s disease in men compared to women. The study, conducted by an international team of neuroscientists, analyzed gene expression patterns in dopamine-producing neurons, which are central to Parkinson’s pathology. Researchers discovered distinct genetic activity linked to sex-specific biological pathways, suggesting these variations could influence disease susceptibility and progression.

The findings reveal that male brain cells exhibit heightened expression of genes associated with oxidative stress and mitochondrial dysfunction, both key factors in Parkinson’s development. Additionally, the study highlights the role of sex hormones, such as testosterone, in modulating these genetic pathways. While the exact mechanisms remain under investigation, the research aligns with epidemiological data showing men account for roughly 55% of Parkinson’s diagnoses globally. The team emphasized that these genetic differences may interact with environmental and hormonal factors to create a gender-specific risk profile.

The study underscores the importance of considering sex as a biological variable in neurological research. By pinpointing genetic markers tied to Parkinson’s vulnerability in men, the work opens avenues for targeted therapies and early intervention strategies. Researchers stressed the need for further studies to validate these findings and explore how sex-based genetic differences might inform personalized treatment approaches for the